The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ofost 5 IU/ml concentrate for solution for infusion or solution for intramuscular injection

5 international unit(s)/millilitre Solution for injection/infusion

AS GrindeksPA22992/001/001

Main Information

Trade NameOfost 5 IU/ml concentrate for solution for infusion or solution for intramuscular injection
Active SubstancesOxytocin
Strength5 international unit(s)/millilitre
Dosage FormSolution for injection/infusion
Licence HolderAS Grindeks
Licence NumberPA22992/001/001

Group Information

ATC CodeH01BB02 oxytocin

Status

Authorised/WithdrawnAuthorised
Licence Issued11/12/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back